Novo Nordisk’s Weight Loss Drug Cagrisema: A New Lawsuit from Investors – Hagens Berman’s Playful Take
Novo Nordisk’s Obesity Treatment CagriSema: A Legal Quagmire In a shocking turn of events, Danish pharmaceutical giant Novo Nordisk A/S (NVO) finds itself in the midst of a contentious class-action lawsuit. The lawsuit, filed by Hagens Berman, alleges that Novo Nordisk misled investors regarding the future of its experimental obesity treatment, CagriSema. The Allegations The…